current
method
accur
diagnosi
influenza
base
cultur
viru
pcr
highli
sensit
specif
requir
specialis
laboratori
facil
highli
train
personnel
case
viral
cultur
take
day
obtain
definit
result
studi
quartz
crystal
microbalancebas
immunosensor
qcm
develop
potenti
evalu
rapid
sensit
detect
influenza
b
virus
laboratorycultur
prepar
clinic
sampl
effect
limit
detect
qcm
stock
prepar
virus
pfuml
associ
observ
frequenc
shift
hz
respect
conjug
nm
gold
nanoparticl
detect
antibodi
improv
mass
sensit
immunosensor
result
increas
sensit
detect
limit
pfuml
prepar
result
frequenc
shift
hz
respect
detect
viru
nasal
wash
techniqu
achiev
overnight
passag
mdck
cultur
prior
analysi
comparison
result
obtain
clinic
sampl
use
exist
rtpcr
shell
vial
cell
cultur
elisa
method
show
qcm
techniqu
compar
sensit
specif
cell
cultur
method
contribut
diagnost
techniqu
manag
patient
viral
infect
increas
consider
last
decad
led
improv
technolog
allow
rapid
accur
sensit
diagnosi
viral
pathogen
increas
rang
infect
rapid
diagnosi
allow
prompt
initi
effect
antivir
therapi
especi
immunocompromis
patient
viral
cultur
usual
combin
immunofluoresc
regard
gold
standard
laboratori
diagnosi
respiratori
virus
et
al
johnston
siegel
howev
test
rapid
clinic
valu
often
limit
case
influenza
virus
isol
identif
cultur
requir
day
diagnosi
ill
whose
durat
typic
day
covalciuc
et
al
rapid
antigen
detect
test
h
less
sensit
sometim
less
specif
cultur
molecular
method
nevertheless
serv
guid
appropri
treatment
antivir
agent
storch
pcr
realtimepcr
techniqu
highli
sensit
rel
specif
rapid
cell
cultur
atmar
et
al
kehl
et
al
liolio
et
al
templeton
et
al
van
elden
et
al
wide
use
diagnosi
respiratori
virus
complex
requir
highli
train
personnel
falseposit
result
due
high
sensit
pcr
amplif
system
storch
su
et
al
accordingli
need
rapid
detect
method
high
sensit
specif
easi
perform
interpret
remain
research
prioriti
su
et
al
consider
effort
direct
toward
develop
simpl
biosensor
detect
virus
pointofcar
test
critchley
dimmock
eun
et
al
hardi
dimmock
su
et
al
wu
et
al
zhou
et
al
biosensor
detect
interact
viral
antigen
specif
antibodi
immunosensor
classifi
accord
type
transduc
use
devic
eun
et
al
mecea
piezoelectr
sensor
quartz
crystal
microbal
qcm
detect
mass
chang
due
molecular
interact
surfac
transduc
gajendragad
et
al
vaughan
et
al
applic
extern
electr
potenti
piezoelectr
materi
quartz
produc
intern
mechan
stress
induc
oscil
electr
field
turn
initi
acoust
wave
throughout
crystal
wave
travel
direct
perpendicular
plate
surfac
ebato
et
al
janshoff
steinem
mecea
sauerbrey
first
describ
relationship
observ
frequenc
decreas
f
deposit
mass
crystal
surfac
air
vacuum
mecea
sauerbrey
vaughan
et
al
frequenc
chang
observ
liquid
pass
qcm
crystal
surfac
also
depend
densiti
viscos
solut
kanazawa
gordon
qcm
devic
rel
simpl
conveni
use
detect
rapid
realtim
respons
bind
event
crystal
surfac
antigenantibodi
interact
lee
chang
park
et
al
et
al
uttenthal
et
al
appli
sever
area
biotechnolog
includ
clinic
diagnosi
janshoff
steinem
nath
chilkoti
environment
monitor
kurosawa
et
al
recent
new
approach
describ
improv
sensit
qcm
biosensor
use
antibodyfunction
nanoparticl
mass
amplif
probe
qcm
sensor
result
signific
enhanc
sensit
chu
et
al
current
studi
qcmbase
immunosensor
develop
evalu
possibl
applic
rapid
sensit
detect
influenza
virus
clinic
specimen
compar
commonli
use
diagnost
techniqu
nasal
wash
sampl
collect
hospit
patient
acut
sign
symptom
australian
winter
provid
two
australian
nation
refer
laboratori
victorian
infecti
diseas
refer
laboratori
vidrl
melbourn
australia
b
collabor
center
refer
research
influenza
melbourn
australia
cultur
prepar
cell
madindarbi
canin
kidney
mdck
line
obtain
csl
ltd
parkvil
australia
use
studi
grown
eagl
minim
essenti
medium
mem
contain
mm
hepe
ethanesulfon
acid
wv
sodium
bicarbon
uml
penicillin
g
gl
streptomycin
gl
amphotericin
b
supplement
fetal
calf
serum
vv
ph
vv
co
incub
c
human
influenza
virus
includ
studi
refer
purpos
grown
embryon
hen
egg
allanto
fluid
contain
viru
clarifi
centrifug
g
min
supernat
fluid
centrifug
g
min
c
use
ti
rotor
beckman
optima
tm
xp
ultracentrifug
beckman
coulter
inc
fullerton
usa
use
subsequ
ultracentrifug
separ
viru
pellet
resuspend
l
tne
trishcl
ph
contain
nacl
mm
edta
buffer
concentr
viru
centrifug
wv
sucros
cushion
wv
sucros
interfac
g
min
viru
collect
aspir
dilut
tne
buffer
pellet
centrifug
g
min
resuspend
tne
buffer
centrifug
wv
sucros
gradient
g
h
c
viru
band
dilut
tne
buffer
centrifug
g
min
c
pellet
resuspend
tne
buffer
store
c
volum
l
nasal
wash
sampl
patient
incub
duplic
tube
contain
confluent
mdck
cultur
ml
serumfre
mem
growth
medium
contain
gml
trypsin
incub
overnight
c
vv
co
incub
sampl
centrifug
g
min
prior
collect
supernat
fluid
qcm
analysi
perform
confluent
mdck
monolay
cultur
previous
describ
tannock
et
al
twentyfourhour
mdck
cell
cultur
prepar
surfac
circular
mm
coverslip
shell
vial
wash
twice
pb
prior
ad
l
fresh
clinic
sampl
cover
slip
shell
vial
centrifug
g
min
ad
ml
mem
contain
gml
trypsin
bovin
pancrea
icn
biomed
seven
hill
nsw
australia
incub
h
c
vv
co
incub
cultur
wash
twice
pb
fix
ad
ml
chill
vv
aceton
pb
min
c
final
cultur
stain
indirect
immunofluoresc
ifa
monoclon
antibodi
mab
specif
nucleoprotein
influenza
b
virus
bartholoma
forb
follow
fitclabel
goat
antimous
antibodi
chemicon
intern
inc
temecula
usa
directigen
influenza
vitro
enzym
immunoassay
becton
dickinson
co
spark
usa
use
rapid
detect
influenza
antigen
nasal
wash
accord
manufactur
instruct
antigen
elisa
develop
use
method
describ
bucher
et
al
well
well
immulon
microtit
plate
thermo
scientif
milford
usa
coat
ad
mab
specif
protein
influenza
b
virus
l
sodium
carbon
buffer
ph
well
leav
overnight
c
unattach
antibodi
remov
wash
dilut
pb
contain
l
purifi
initi
concentr
gml
ad
individu
well
l
dilut
chicken
antisera
prepar
purifi
prepar
protein
either
use
primari
antibodi
wash
l
dilut
goat
antimousehrp
conjug
chemicon
intern
inc
temecula
usa
use
secondari
detect
antibodi
follow
color
develop
use
tetramethylbenzidin
tmb
becton
dickinson
co
spark
usa
substrat
absorb
valu
determin
use
elisa
plate
reader
dynatech
mr
dynatech
laboratori
chantilli
usa
set
nm
viral
rna
extract
allanto
fluid
nasal
wash
sampl
use
qiaamp
viral
rna
mini
kit
qiagen
hamburg
gmbh
rtpcr
perform
use
titan
tm
one
tube
rtpcr
system
roch
diagnost
mannheim
gmbh
accord
manufactur
instruct
egggrown
influenza
virus
nasal
sampl
test
rtpcr
use
method
describ
poddar
maxtek
rqcm
sensor
coupl
flow
inject
system
use
mm
mhz
quartz
crystal
mount
maxtek
crystal
holder
maxtek
inc
cypress
usa
oscillatorfrequ
counter
collect
output
signal
oscil
output
measur
frequenc
chang
f
resist
chang
chang
mass
flow
inject
system
consist
fluid
circuit
flowthrough
cell
flow
cell
maxtek
inc
cypress
usa
rheodyn
inject
switch
valv
model
rheodyn
llc
rohnert
park
usa
razel
syring
pump
model
razel
scientif
instrument
inc
stamford
usa
schemat
diagram
apparatu
use
work
shown
fig
experi
carri
room
temperatur
piezoelectr
quartz
crystal
immers
n
naoh
min
remov
impur
crystal
surfac
wash
distil
water
air
dri
place
min
n
hcl
wash
distil
water
ethanol
dri
stream
nitrogen
park
et
al
one
hundr
microlitr
protein
dissolv
pb
mgml
ad
gold
electrod
quartz
crystal
incub
room
temperatur
humid
environ
h
analysi
bind
characterist
mab
elisa
experi
indic
optimum
bind
achiev
gml
mab
specif
protein
gml
protein
acoat
crystal
incub
l
antibodi
solut
concentr
h
c
humidifi
chamber
rins
pb
distil
water
dri
stream
nitrogen
gold
nanoparticl
prepar
use
modif
method
grabar
et
al
total
ml
gold
iii
chlorid
trihydr
haucl
distil
water
brought
boil
vigor
stir
ml
roundbottom
flask
follow
addit
ml
wv
trisodium
citrat
solut
boil
addit
min
allow
cool
stir
min
colloid
solut
store
dark
bottl
c
glasswar
use
thoroughli
clean
aqua
regia
hcl
hno
rins
distil
water
ovendri
prior
use
antibodynanoparticl
conjug
prepar
addit
g
mab
specif
protein
either
ml
gold
nanoparticl
suspens
contain
nanoparticl
mm
sodium
carbon
buffer
ph
follow
incub
room
temperatur
gentl
mix
h
l
wv
bsa
pb
ad
mix
min
room
temperatur
block
free
bind
site
nanoparticl
stabil
nanoparticl
suspens
antibodynanoparticl
conjug
centrifug
g
min
supernat
fluid
contain
unbound
antibodi
discard
redcolour
antibodynanoparticl
conjug
pellet
gentli
resuspend
ml
tbsbsa
mm
tri
ph
contain
mm
nacl
wv
bsa
final
second
centrifug
step
g
min
supernat
fluid
remov
antibodycolloid
gold
conjug
pellet
resuspend
l
tbsbsa
store
c
chu
et
al
reson
frequenc
shift
qcm
sensor
influenc
mani
factor
chang
mass
viscos
dielectr
constant
solut
ionic
statu
crystal
interfac
buffer
solut
kim
et
al
mecea
park
et
al
accordingli
number
paramet
includ
effici
block
buffer
ph
reaction
buffer
flow
rate
concentr
antibodi
orient
antibodi
presenc
protein
optim
determin
limit
detect
data
shown
follow
immobil
mab
crystal
electrod
dilut
either
pfuml
pb
inject
continu
onto
immunosensor
constant
flow
rate
mlh
use
syring
pump
flow
path
sensor
rins
pb
prior
load
viru
dilut
analys
typic
record
frequenc
chang
observ
bind
either
viru
shown
fig
b
show
frequenc
shift
rang
hz
hz
virus
respect
depend
titer
viru
ad
data
show
frequenc
chang
hz
introduc
viru
sampl
sensor
surfac
min
postinject
data
suggest
effect
minimum
detect
limit
pfuml
associ
frequenc
shift
hz
respect
n
gold
nanoparticl
conjug
antibodi
use
attempt
increas
sensit
qcm
immunosensor
detect
influenza
virus
diamet
nanoparticl
use
determin
nm
transmiss
electron
microscopi
tem
conjug
antiinfluenza
mab
nanoparticl
confirm
visibl
absorb
measur
show
unconjug
nanoparticl
absorb
maximum
max
nm
increas
nm
follow
conjug
wavelength
shift
nm
indic
protein
bound
surfac
nanoparticl
result
increas
primari
gold
plasmon
reson
peak
nath
chilkoti
follow
attach
antibodi
quartz
crystal
purifi
prepar
titer
pfuml
pb
inject
flow
rate
mlh
min
pb
pass
min
remov
unbound
antigen
follow
inject
nanoparticlemab
conjug
specif
influenza
b
virus
frequenc
chang
follow
bind
mabnanoparticl
conjug
cognat
antigen
record
min
typic
sensor
profil
purifi
shown
fig
c
data
lowest
detect
infecti
titer
purifi
prepar
pfuml
gml
correspond
frequenc
shift
hz
respect
n
neg
control
background
measur
absenc
viru
hz
nanoparticleantibodi
conjug
prepar
use
comparison
frequenc
shift
respons
differ
viral
dilut
rang
pfuml
determin
presenc
absenc
nanoparticl
summar
tabl
result
support
shown
fig
c
conjug
nanoparticl
virusspecif
mab
substanti
increas
sensit
assay
use
nanoparticleantibodi
conjug
result
increas
frequenc
shift
respons
detect
pfuml
respect
compar
measur
taken
without
use
nanoparticl
higher
titer
differ
sensit
less
pfuml
increas
frequenc
shift
observ
tabl
fig
fig
show
relationship
infecti
titer
frequenc
chang
record
semilogarithm
plot
analysi
indic
approxim
linear
relationship
viru
concentr
observ
frequenc
chang
viru
frequenc
chang
observ
virus
titer
rang
pfuml
lie
within
calibr
rang
thu
allow
estim
viru
titer
unknown
sampl
dilut
purifi
pfuml
use
spike
vv
nasal
wash
specimen
pb
normal
asymptomat
volunt
dilut
sampl
mix
centrifug
g
min
supernat
collect
analysi
signific
nois
frequenc
respons
observ
sampl
includ
neg
control
consist
sampl
spike
volum
pb
without
viru
data
shown
therefor
direct
detect
viru
dilut
nasal
wash
techniqu
appear
practic
signal
nois
result
test
clinic
sampl
could
elimin
simpl
pretreat
clinic
sampl
either
microfiltr
anodisc
filter
whatman
plc
kent
uk
overnight
digest
mgml
unit
chicken
egg
white
lysozym
sigmaaldrich
st
loui
mo
usa
follow
centrifug
g
min
data
shown
howev
sampl
inocul
mdck
cell
cultur
incub
overnight
prior
qcm
analysi
signific
stabl
signal
frequenc
shift
cultur
mainten
fluid
posit
sampl
observ
rang
copi
cdnaml
fig
stock
purifi
pfuml
equival
copiesml
copiesml
b
signal
appear
absenc
visibl
cpe
infect
cultur
procedur
use
subsequ
evalu
qcm
techniqu
clinic
sampl
result
test
clinic
sampl
summar
tabl
base
data
fig
readout
copiesml
copiesml
copiesml
copiesml
copiesml
neg
howev
rtpcrposit
specimen
neg
shell
vial
cell
cultur
elisa
method
influenza
b
virus
respect
twelv
nine
sampl
posit
rtpcr
techniqu
neg
qcm
npqcm
method
shown
tabl
respect
sensit
test
detect
influenza
b
virus
shell
vial
standard
cell
cultur
elisa
directigen
flu
test
qcm
npqcm
test
influenza
influenza
b
virus
tabl
specif
posit
neg
predict
valu
detect
viru
shown
tabl
highest
number
falseneg
result
obtain
directigen
flu
test
studi
conduct
light
continu
need
rapid
sensit
method
identif
antigen
character
influenza
virus
epidemiolog
purpos
select
vaccin
strain
qcmbase
immunosensor
develop
evalu
rapid
detect
influenza
b
virus
nasal
wash
sampl
obtain
australian
winter
sensit
compar
pcr
shell
vial
standard
cell
cultur
method
antigen
elisa
commerci
avail
directigen
flu
kit
influenza
virus
one
import
factor
affect
sensit
qcm
sensor
optim
concentr
antibodi
immobil
crystal
surfac
lead
improv
reaction
kinet
avoid
unfavour
effect
minim
nonspecif
bind
jenkin
et
al
luppa
et
al
studi
optimum
monoclon
antibodi
concentr
immobil
qcm
maximum
sensit
gml
gml
virus
result
consist
optim
concentr
use
elisa
assay
data
shown
optim
antibodi
concentr
determin
antigen
concentr
vari
determin
optim
antigen
antibodi
ratio
maxim
sensit
sensor
result
present
fig
show
infecti
titer
viru
sampl
directli
proport
mass
accumul
immobil
monolay
turn
proport
rate
frequenc
shift
record
result
obtain
differ
concentr
purifi
virus
fig
b
show
lowest
detect
infecti
titer
purifi
virus
pfuml
gml
use
similar
approach
protein
aimmobil
antiviru
antibodi
limit
pfuml
human
herp
virus
howev
zuo
et
al
abl
detect
littl
gml
sar
coronaviru
sarscov
sputa
ga
phase
use
qcm
sensor
coat
protein
polyclon
antibodi
studi
antiinfluenza
b
monoclon
antibodi
bound
nm
gold
nanoparticl
conjug
use
improv
mass
sensit
sensor
influenza
detect
shown
fig
c
summar
tabl
lowest
detect
viral
infect
titer
purifi
pfuml
gml
increas
sensit
qcm
sensor
use
nanoparticlebound
antiinfluenza
b
monoclon
antibodi
given
viral
titr
nasal
wash
sampl
symptomat
patient
usual
pfuml
greater
step
clearli
increas
potenti
biosensor
detect
influenza
viru
clinic
sampl
howev
data
present
fig
c
summar
tabl
indic
use
nanoparticl
result
proport
increas
sensit
qcm
sensor
detect
influenza
virus
sampl
high
infecti
titer
maximum
enhanc
sensit
observ
rang
pfuml
suggest
adsorpt
excess
antibodycolloid
gold
conjug
electrod
surfac
lead
steric
hindranc
effect
chu
et
al
order
quantit
virus
detect
qcm
sensor
calibr
curv
establish
qcm
npqcm
techniqu
fig
curv
describ
relationship
frequenc
shift
titer
influenza
viru
suspens
inject
sensor
data
plot
logarithmiclinear
scale
appar
linear
relationship
amount
antigen
frequenc
shift
observ
similar
relationship
observ
nanoparticleconjug
antibodi
use
instead
antibodi
alon
base
appar
linear
semilogarithm
relationship
frequenc
shift
viru
concentr
use
nanoparticleantibodi
conjug
possibl
use
calibr
curv
determin
unknown
viral
titer
sampl
store
optim
condit
within
rang
pfuml
fig
basic
paramet
develop
studi
qcmbase
immunosensor
subsequ
appli
detect
influenza
b
virus
clinic
specimen
studi
capac
qcm
npqcm
method
detect
influenza
virus
nasal
wash
patient
influenzalik
symptom
compar
current
use
method
includ
rtpcr
standard
cell
cultur
shell
vial
elisa
directigen
flu
influenza
viru
method
qcm
offer
number
potenti
advantag
exist
techniqu
includ
obviat
need
label
techniqu
measur
bind
reaction
viru
antibodi
use
short
measur
time
oper
simplic
low
cost
opportun
reus
crystal
sensor
potenti
onlin
data
collect
qcm
techniqu
develop
studi
shown
sensit
shell
vial
method
npqcm
techniqu
sensit
shell
vial
method
equal
sensit
cell
cultur
tabl
requir
addit
step
involv
use
secondari
nanoparticleantibodi
conjug
direct
detect
viru
nasal
wash
sampl
qcm
possibl
signific
frequenc
fluctuat
occur
possibl
due
viscos
sampl
heterogen
natur
clinic
sampl
appear
inher
limit
diagnost
test
utilis
piezoelectr
immunosensor
wu
et
al
attempt
reduc
viscos
nasal
wash
sampl
infect
patient
centrifug
microfiltr
prior
analysi
immunosensor
prove
unsuccess
data
shown
howev
zuo
et
al
overcam
limit
atomis
sputum
sampl
contain
sarscov
ultrason
prior
adsorpt
detect
immunosensor
initi
studi
addit
overnight
cultur
step
use
overcom
viscos
effect
sputum
sampl
result
increas
process
time
day
sensit
test
detect
influenza
b
shell
vial
standard
cell
cultur
elisa
directigen
flu
test
qcm
npqcm
test
influenza
respect
tabl
result
differ
quach
et
al
report
sensit
specif
compar
rtpcr
howev
present
studi
frozen
sampl
use
viru
newli
collect
sampl
could
expect
readili
detect
sinc
proteolysi
denatur
influenza
antigen
previous
observ
store
nasal
wash
quach
et
al
data
influenza
b
combin
sensit
method
descend
order
rtpcr
npqcm
qcm
standard
cell
cultur
shell
vial
elisa
tabl
time
requir
complet
test
directigen
flu
min
rtpcr
day
elisa
day
shell
vial
day
qcm
npqcm
day
standard
cell
cultur
method
day
includ
time
repassag
initi
neg
sampl
egggrown
prepar
could
detect
qcm
npqcm
method
within
min
h
respect
despit
requir
similar
time
interv
day
complet
test
involv
blind
passag
clinic
specimen
npqcm
method
describ
econom
simpler
sensit
object
interpret
wide
use
shell
vial
assay
often
regard
gold
standard
requir
use
ifa
cell
cultur
refin
especi
pretreat
sampl
reduc
viscos
effect
direct
analysi
patient
specimen
would
greatli
increas
use
immunosens
techniqu
save
consider
time
clinic
set
